CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
OVERVIEW
Growing bodies of clinical evidence continue to support the utility of various novel treatment options for mitral regurgitation (MR). With the recent expansion of indications for devices to treat functional mitral regurgitation (FMR), continued review of emerging data is essential to realizing optimized patient outcomes in both surgical and transcatheter treatment of MR. This program will provide comprehensive overview of recent clinical trials and practical implications, case-based review of MR treatment options, and discussion of approaches for selecting appropriate surgical or transcatheter MR therapies.
LEARNING OBJECTIVES
By the end of this activity, participants should be able to:
1) Identify unmet needs of patient care in mitral valve disease
2) Describe developments in TMVR procedures and lessons learned
3) Summarize perspectives on future treatments for mitral regurgitation
TARGET AUDIENCE
This activity is designed for interventional cardiologists, cardiac surgeons, clinical cardiologists, vascular medicine specialists, and other healthcare professionals.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
FACULTY DISCLOSURE SUMMARY
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E) Equity (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
Gorav Ailawadi: (C/H/S) Abbott, Admedus, Cephea, Edwards Lifesciences, Medtronic
Vinayak N. Bapat: (C/H/S) Boston Scientific, Edwards Lifesciences, Medtronic
Marc P. Pelletier: (C/H/S) Abbott, Liva Nova, Medtronic
Sean P. Pinney: (C/H/S) Abbott, Medtronic
Basel Ramlawi: (G/R) (C/H/S) Medtronic, Liva Nova, (C/H/S) AtriCure
Michael J. Reardon: (C/H/S) Medtronic
Planning Committee
Robert Blanco (Planner)
(S) Cardiovascular Research Foundation
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation. It is supported through an educational grant from Medtronic, Inc. and was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Robert Blanco at rblanco@crf.org .